Mirna Therapeutics and the University of California, San Francisco (UCSF) will work together to evaluate the capacity of specific miRNAs to reduce or eliminate tumors in mouse models of cancer.


The collaboration will include miRNAs that were discovered at both Mirna and UCSF as well as small RNAs that will be identified in research using mouse and cell models from UCSF.

Previous articlePfizer Halts Phase III Trial with Pancreatic Cancer Drug
Next articleSymphogen Pockets Over $42M